Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis
Predicts need for VTE prophylaxis in admitted patients.
INSTRUCTIONS
Note: this score is different from the Geneva Score (Revised) for PE, which diagnoses PE in patients presenting with relevant signs and symptoms.
0 points
Geneva Risk Score for VTE Prophylaxis
0.6 %
VTE risk (composite of symptomatic VTE or 90-day VTE mortality)
Low risk
VTE prophylaxis NOT indicated
Dr. Pierre Chopard
About the creator
Pierre Chopard, MD, MSc, is an associate professor at the University of Geneva, in Switzerland. He is also the chief medical officer of the Care Quality Division at Geneva University Hospitals. Dr. Chopard’s research interests include healthcare quality and risk management.
To view Dr. Pierre Chopard's publications, visit PubMed
Are you Dr. Pierre Chopard? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.